Target intelligence / Profile preview

Protein kinase C-like 1 (Pkc1)

Target
Pkc1
Molecular classification
Enzyme, Serine/threonine-protein kinase, Protein kinase C family
01

Overview

Protein kinase C-like 1 (Pkc1) is a critical serine/threonine kinase in fungi, such as Saccharomyces cerevisiae and Candida albicans, where it functions as the primary regulator of the cell wall integrity (CWI) signaling pathway (Levin, 2005, Microbiol Mol Biol Rev). It is activated by the small GTPase Rho1 and subsequently triggers a downstream mitogen-activated protein kinase (MAPK) cascade involving Bck1, Mkk1/2, and Slt2/Mpk1 (UniProt P24583). This pathway is essential for maintaining the fungal cell wall during growth, morphogenesis, and environmental stress. Because Pkc1 is indispensable for fungal survival and possesses structural features distinct from human protein kinase C (PKC) isoforms, it is a highly attractive target for antifungal therapy (Sussman et al., 2004, Eukaryot Cell). Inhibition of Pkc1 results in cell wall weakening, osmotic fragility, and cell death. Compounds like cercosporamide have been identified as selective inhibitors of Pkc1, showing efficacy against various pathogenic fungi (PubMed: 15507491). Therapeutic challenges include achieving high selectivity over human PKC isoforms to minimize systemic toxicity, while research continues to explore Pkc1 inhibitors as a means to combat drug-resistant fungal infections.

Other names
PKC1STT1Cell wall integrity kinaseSerine/threonine-protein kinase PKC1
02

Mechanism of action

Inhibition of the cell wall integrity (CWI) signaling pathway, leading to defective cell wall synthesis and osmotic lysis of fungal cells.

03

Biological functions

Signal transductionCell wall integrityCell cycle regulationStress responseCytokinesis
04

Disease associations

Fungal infectionCandidiasisCryptococcosisAspergillosis
05

Safety considerations

Cross-reactivity with human protein kinase C (PKC) isoformsDevelopment of antifungal resistanceLow aqueous solubility of certain inhibitors
06

Interacting drugs

Cercosporamide

2 more in the full profile.

07

Biomarkers

Mpk1 phosphorylation levelsSlt2 phosphorylation levelsCell wall glucan content

Beyond the preview

Go deeper on Protein kinase C-like 1 (Pkc1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein kinase C-like 1 (Pkc1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call